Moteur de recherche d’entreprises européennes
Financement de l’UE (9 033 750 €) : Outils d’aide à la décision fondés sur la conception et fondés sur les données : produire de meilleurs résultats en matière de cancer grâce à la recherche centrée … Hor29/07/2022 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Outils d’aide à la décision fondés sur la conception et fondés sur les données : produire de meilleurs résultats en matière de cancer grâce à la recherche centrée sur l’utilisateur
Patients with cancer often have to make complex decisions about treatment, with the options varying in risk profiles and effects on survival and quality of life. Data-driven decision-support tools (DSTs) have the potential to empower patients, support personalized care, improve health outcomes, and promote health equity (optimal decisions also for underserved groups). However, DSTs currently seldom consider quality of life or individual preferences, and their use in clinical practice remains limited. To address these challenges, the 4D PICTURE consortium will further develop a promising methodology, MetroMapping, to redesign care paths that include novel DSTs. We will better predict treatment outcomes by developing innovative algorithms and incorporating patient experiences, values and preferences, using AI-based models. In co-creation with patients and other stakeholders, we will develop data-driven DSTs for patients with breast cancer, prostate cancer and melanoma. We will evaluate these DSTs as part of MetroMapping as well as stand-alone, to ensure their sustainability as well as addressing social and ethical issues. We will explore the generalizability of MetroMapping and the DSTs to other types of cancer and across other EU member states. Improved care paths integrating comprehensive DSTs will empower patients, their significant others and health care providers in decision making, and strengthen care at the system level by improving resilience and efficiency. Whereas the 4D PICTURE consortium includes leaders in modelling, AI, decision making, citizen science, service design, ethics, risk communication, and policy making, this project will impact clinical practice and science across Europe and beyond.
| University of Lancaster | ? |
| ACADEMISCH ZIEKENHUIS LEIDEN | 1 580 000 € |
| CHARITE - UNIVERSITAETSMEDIZIN BERLIN | 362 500 € |
| Designskolen Kolding | 436 250 € |
| ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM | 1 893 000 € |
| European Cancer Organisation | 103 750 € |
| Fractal Strategy SL | 255 000 € |
| Fundacion Instituto de Investigacion Sanitaria Aragon | 247 500 € |
| Onkoloski Institut Ljubljana | 465 000 € |
| PANTON B.V. | 395 000 € |
| Region Hovedstaden | 160 000 € |
| Region Stockholm | 400 000 € |
| Region Syddanmark | 769 500 € |
| TECHNISCHE UNIVERSITAET MUENCHEN | 457 500 € |
| TECHNISCHE UNIVERSITEIT DELFT | 200 000 € |
| Umit Tirol - Private Universitat FUR Gesundheitswissenschaften UND Technologie GmbH | 552 500 € |
| Universidad de Zaragoza | 756 250 € |
https://cordis.europa.eu/project/id/101057332
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : University of Lancaster, Lancaster, Royaume Uni.
